In this retrospective study, researchers assessed whether high-dose-rate intraoperative radiotherapy can achieve high tumor control in unfavorable soft tissue sarcoma of the extremities.

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...

Ravin Ratan, MD, MEd, MD Anderson, delves into how treatment paradigms and considerations differ between adult patients and pediatric patients who have soft tissue sarcomas. Ravin Ratan, MD, MEd, ...

Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

CLD-201, an allogeneic adipose stem-cell loaded oncolytic virus, received FDA fast track designation for soft tissue sarcoma treatment. Fast track designation expedites drug development and review for ...

While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...

A new editorial was published in Volume 16 of Oncotarget on July 16, 2025, titled "microRNAs in soft tissue sarcoma: State of the art and barriers to translation." In this article, Elizaveta K.

Every year, the month of July is marked as Sarcoma Awareness Month—a time when patients, caregivers, doctors, and advocates across the world come together to shine a light on this rare and often ...